Bahouth S W, Malbon C C
Department of Pharmacological Sciences, School of Medicine, State University of New York, Stony Brook 11794-8651.
Biochem J. 1987 Dec 1;248(2):557-66. doi: 10.1042/bj2480557.
Beta-Adrenergic receptors from basal membranes of human placenta were purified from digitonin extracts by sequential rounds of affinity chromatography, hydrophobic chromatography, ion-exchange chromatography and steric-exclusion h.p.l.c. Basal membranes display both beta 1- and beta 2-adrenergic receptors, in the ratio 65:35. Affinity chromatography, hydrophobic chromatography on heptylamine-Sepharose and ion-exchange chromatography on DEAE-Sephacel removed most of the contaminating proteins, and final purification of the receptor to apparent homogeneity was achieved by steric-exclusion h.p.l.c. The purified receptors showed Mr 67000 on SDS/polyacrylamide-gel electrophoresis under reducing conditions. Specific binding of radioligand to the purified beta-adrenergic receptors displayed stereoselectivity, and the agonist competition profiles demonstrated the presence of both beta 1- and beta 2-receptors. By using the subtype-selective ligands CGP-20712A (beta 1-selective) and ICI-118,551 (beta 2-selective), the purified Mr-67000 species was shown to be composed of equivalent amounts of beta 1- and beta 2-adrenergic receptors. Affinity chromatography on Sepharose-alprenolol and sequential elution with 1 microM-CGP-20712A followed by 100 microM(-)-alprenolol permitted beta 1-adrenergic receptors to be resolved from the mixture of beta 1-/beta 2-adrenergic receptors. The pharmacologically distinct human beta 1 and beta 2-adrenergic receptors are shown to be structurally very similar peptides.
人胎盘基底膜中的β-肾上腺素能受体通过依次进行亲和层析、疏水层析、离子交换层析和空间排阻高效液相色谱法,从洋地黄皂苷提取物中纯化得到。基底膜同时显示β1和β2肾上腺素能受体,比例为65:35。亲和层析、庚胺-琼脂糖上的疏水层析以及DEAE-琼脂糖凝胶上的离子交换层析去除了大部分污染蛋白,通过空间排阻高效液相色谱法最终将受体纯化至表观均一。在还原条件下,经十二烷基硫酸钠/聚丙烯酰胺凝胶电泳分析,纯化后的受体显示分子量为67000。放射性配体与纯化的β-肾上腺素能受体的特异性结合表现出立体选择性,激动剂竞争曲线表明同时存在β1和β2受体。使用亚型选择性配体CGP-20712A(β1选择性)和ICI-118,551(β2选择性),显示纯化的分子量为67000的物质由等量的β1和β2肾上腺素能受体组成。在琼脂糖-阿普洛尔上进行亲和层析,然后依次用1μM CGP-20712A和100μM(-)-阿普洛尔洗脱,可从β1/β2肾上腺素能受体混合物中分离出β1肾上腺素能受体。药理学上不同的人β1和β2肾上腺素能受体显示为结构非常相似的肽。